• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Trending
Screeners
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6870.39
6870.39
6870.39
6895.79
6858.28
+13.27
+ 0.19%
--
DJI
Dow Jones Industrial Average
47954.98
47954.98
47954.98
48133.54
47871.51
+104.05
+ 0.22%
--
IXIC
NASDAQ Composite Index
23578.12
23578.12
23578.12
23680.03
23506.00
+72.99
+ 0.31%
--
USDX
US Dollar Index
98.950
99.030
98.950
99.060
98.740
-0.030
-0.03%
--
EURUSD
Euro / US Dollar
1.16426
1.16443
1.16426
1.16715
1.16277
-0.00019
-0.02%
--
GBPUSD
Pound Sterling / US Dollar
1.33312
1.33342
1.33312
1.33622
1.33159
+0.00041
+ 0.03%
--
XAUUSD
Gold / US Dollar
4197.91
4197.91
4197.91
4259.16
4191.87
-9.26
-0.22%
--
WTI
Light Sweet Crude Oil
59.809
60.061
59.809
60.236
59.187
+0.426
+ 0.72%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

Waymo, The Self-driving Car Division Of Google's Parent Company Alphabet, Has Voluntarily Applied To The National Highway Traffic Safety Administration (NHTSA) For A Software Recall

Share

Fitch On Hungary: Frequent Revisions To Government's Targets Have Weakened Policy Predictability And Increased Fiscal Risks

Share

Fitch On Hungary: Continues To Rely On Russian Energy Imports, Leaving It Exposed To Potential Supply Disruptions And Price Changes

Share

On Friday (December 5), In Late New York Trading, S&P 500 Futures Rose 0.20%, Dow Jones Futures Rose 0.22%, And NASDAQ 100 Futures Rose 0.45%. Russell 2000 Futures Fell 0.35%

Share

The US Dollar Fell Further Against The Canadian Dollar, With The Decline Widening To 1%

Share

Libya's Oil Terminals Of Zueitina, Ras Lanuf , Es Sider, Brega Forced To Shutdown Due To Bad Weather - Two Engineers To Reuters

Share

Sag-Aftra: Any Decision About Our Position On Wbd Deal Will Be Made After Analysis Of Deal Details , With Focus On Jobs & Production Commitments

Share

Canada Says It Has Removed Syria From Canada's List Of Foreign State Supporters Of Terrorism

Share

Most Of The 11 Sectors In The S&P 500 Closed Lower, With Utilities Down 0.98%, Energy Down 0.43%, Materials Down 0.39%, While Consumer Discretionary Rose 0.44%, Information Technology/technology Rose 0.45%, And Telecommunications Rose 0.95%

Share

[Most US Equity ETFs Closed Lower] On Friday (December 5), The VIX (Volatility Index) Fell 1.19%, The Soybean Fund Fell 1.16%, The US 20+ Year Equity-Bond ETF Fell 0.46%, The Russell 2000 ETF Fell 0.42%, The Gold ETF Fell 0.18%, The US Real Estate ETF, The Long US Dollar Index, The Long Japanese Yen, The Long Euro, And The Barclays US Convertible Bond ETF Fell By A Maximum Of 0.11%, While The S&P 500 ETF And The Dow Jones ETF Fell By A Maximum Of 0.2%. The Agricultural Commodities Fund Rose 0.23%, The NASDAQ 100 ETF Rose 0.41%, And The US Brent Oil Price Fund And The Emerging Market ETF Rose 0.75% Respectively

Share

[US Stock Sector ETFs Show Mixed Results] On Friday (December 5), The Global Airline ETF Rose 1.93%, The Semiconductor ETF Rose 0.78%, The Technology ETF Rose 0.73%, And The Global Technology Stock Index ETF, Consumer Discretionary ETF, And Internet Stock Index ETF Also Rose By A Maximum Of 0.6%. The Banking ETF And Regional Bank ETF Fell 0.23%, And The Energy ETF Fell 0.41%

Share

S&P On Azerbaijan: Positive Outlook Reflected Our View That Tensions Between Azerbaijan And Armenia Have Eased

Share

Mexican President Sinbaum: He Agrees With US President Trump That They Will Continue To Work To Resolve Trade Issues

Share

Federal Reserve: U.S. Bank Deposits Totaled $18.526 Trillion Last Week, Compared With $18.428 Trillion The Previous Week

Share

US Stock Market Closing Report | On Friday (December 5), The Magnificent 7 Index Rose 0.17% To 208.74 Points, A Weekly Gain Of 0.82%. The "mega-cap" Tech Stock Index Rose 0.64% To 406.36 Points, A Weekly Gain Of 0.95%

Share

Citigroup's Stock Price Has Exceeded Its Book Value For The First Time Since 2018

Share

Brazil's Benchmark Stock Index Bovespa Closes Down 4.25%, Biggest Fall Since February 2021 - Preliminar Data

Share

The Nasdaq Golden Dragon China Index Closed Up 1.3% Initially, With A Cumulative Gain Of About 0.5% This Week, Achieving A V-shaped Reversal. Among Popular Chinese Concept Stocks, Baidu Closed Up 5.8%, GDS Holdings Rose 4.5%, XPeng Motors Rose 2.7%, New Oriental Education & Technology Group Rose 2.5%, While Pony.ai Fell 2.8% And Canadian Solar Fell 3.7%

Share

Argentina's Merval Index Closed Down 1.59%, Nearing 3.04 Million Points, But Rose 0.68% For The Week

Share

The 10-year US Treasury Yield Rose More Than 3 Basis Points On The Day Of The Pce Inflation Data Release, With A Cumulative Increase Of More Than 12 Basis Points This Week. On Friday (December 5th) In Late New York Trading, The Yield On The 10-year US Treasury Note Rose 3.69 Basis Points To 4.1351%, A Cumulative Increase Of 12.18 Basis Points This Week. The Yield On The 2-year US Treasury Note Rose 3.77 Basis Points To 3.5603%, A Cumulative Increase Of 7.10 Basis Points This Week; The Yield On The 30-year US Treasury Note Rose 3.41 Basis Points To 4.7888%. The Yield On The 10-year Treasury Inflation-Protected Securities (TPS) Rose 3.64 Basis Points To 1.8428%; The Yield On The 2-year TPS Rose 1.44 Basis Points To 1.0566%; And The Yield On The 30-year TPS Rose 3.59 Basis Points To 2.5663%

TIME
ACT
FCST
PREV
Italy Retail Sales MoM (SA) (Oct)

A:--

F: --

P: --

Euro Zone Employment YoY (SA) (Q3)

A:--

F: --

P: --

Euro Zone GDP Final YoY (Q3)

A:--

F: --

P: --

Euro Zone GDP Final QoQ (Q3)

A:--

F: --

P: --

Euro Zone Employment Final QoQ (SA) (Q3)

A:--

F: --

P: --

Euro Zone Employment Final (SA) (Q3)

A:--

F: --

P: --
Brazil PPI MoM (Oct)

A:--

F: --

P: --

Mexico Consumer Confidence Index (Nov)

A:--

F: --

P: --

Canada Unemployment Rate (SA) (Nov)

A:--

F: --

P: --

Canada Labor Force Participation Rate (SA) (Nov)

A:--

F: --

P: --

Canada Employment (SA) (Nov)

A:--

F: --

P: --

Canada Part-Time Employment (SA) (Nov)

A:--

F: --

P: --

Canada Full-time Employment (SA) (Nov)

A:--

F: --

P: --

U.S. Personal Income MoM (Sept)

A:--

F: --

P: --

U.S. PCE Price Index YoY (SA) (Sept)

A:--

F: --

P: --

U.S. PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Personal Outlays MoM (SA) (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index YoY (Sept)

A:--

F: --

P: --

U.S. UMich 5-Year-Ahead Inflation Expectations Prelim YoY (Dec)

A:--

F: --

P: --

U.S. Real Personal Consumption Expenditures MoM (Sept)

A:--

F: --

P: --

U.S. 5-10 Year-Ahead Inflation Expectations (Dec)

A:--

F: --

P: --

U.S. UMich Current Economic Conditions Index Prelim (Dec)

A:--

F: --

P: --

U.S. UMich Consumer Sentiment Index Prelim (Dec)

A:--

F: --

P: --

U.S. UMich 1-Year-Ahead Inflation Expectations Prelim (Dec)

A:--

F: --

P: --

U.S. UMich Consumer Expectations Index Prelim (Dec)

A:--

F: --

P: --

U.S. Weekly Total Rig Count

A:--

F: --

P: --

U.S. Weekly Total Oil Rig Count

A:--

F: --

P: --

U.S. Unit Labor Cost Prelim (SA) (Q3)

--

F: --

P: --

U.S. Consumer Credit (SA) (Oct)

A:--

F: --

P: --

China, Mainland Foreign Exchange Reserves (Nov)

--

F: --

P: --

China, Mainland Exports YoY (USD) (Nov)

--

F: --

P: --

China, Mainland Imports YoY (CNH) (Nov)

--

F: --

P: --

China, Mainland Imports YoY (USD) (Nov)

--

F: --

P: --

China, Mainland Imports (CNH) (Nov)

--

F: --

P: --

China, Mainland Trade Balance (CNH) (Nov)

--

F: --

P: --

China, Mainland Exports (Nov)

--

F: --

P: --

Japan Wages MoM (Oct)

--

F: --

P: --

Japan Trade Balance (Oct)

--

F: --

P: --

Japan Nominal GDP Revised QoQ (Q3)

--

F: --

P: --

Japan Trade Balance (Customs Data) (SA) (Oct)

--

F: --

P: --

Japan GDP Annualized QoQ Revised (Q3)

--

F: --

P: --
China, Mainland Exports YoY (CNH) (Nov)

--

F: --

P: --

China, Mainland Trade Balance (USD) (Nov)

--

F: --

P: --

Germany Industrial Output MoM (SA) (Oct)

--

F: --

P: --

Euro Zone Sentix Investor Confidence Index (Dec)

--

F: --

P: --

Canada Leading Index MoM (Nov)

--

F: --

P: --

Canada National Economic Confidence Index

--

F: --

P: --

U.S. Dallas Fed PCE Price Index YoY (Sept)

--

F: --

P: --

U.S. 3-Year Note Auction Yield

--

F: --

P: --

U.K. BRC Overall Retail Sales YoY (Nov)

--

F: --

P: --

U.K. BRC Like-For-Like Retail Sales YoY (Nov)

--

F: --

P: --

Australia Overnight (Borrowing) Key Rate

--

F: --

P: --

RBA Rate Statement
RBA Press Conference
Germany Exports MoM (SA) (Oct)

--

F: --

P: --

U.S. NFIB Small Business Optimism Index (SA) (Nov)

--

F: --

P: --

Mexico Core CPI YoY (Nov)

--

F: --

P: --

Mexico 12-Month Inflation (CPI) (Nov)

--

F: --

P: --

Mexico PPI YoY (Nov)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          Halper Sadeh Llc Encourages Gifi, Avdl, Jamf, Cde Shareholders To Contact The Firm To Discuss Their Rights

          Reuters
          Avadel Pharmaceuticals
          -0.07%
          Coeur Mining
          -1.49%
          Gulf Island Fabrication
          -0.04%
          Jamf Holding
          -0.04%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Reg - Geode Capital Mgmnt Avadel Pharma Plc - Form 8.3 - Avadel Pharmaceuticals

          Reuters
          Avadel Pharmaceuticals
          -0.07%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          $Hareholder Alert: The M&A Class Action Firm Continues To Investigate The Merger—Gifi, Avdl, Smlr, And Cde

          Reuters
          Avadel Pharmaceuticals
          -0.07%
          Coeur Mining
          -1.49%
          Gulf Island Fabrication
          -0.04%
          Semler Scientific
          -7.98%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - Geode Capital Mgmnt Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.07%
          RNS Number : 3378K Geode Capital Management LLC 04 December 2025  

          Ap27

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          Geode Capital Management, LLC

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          Avadel Pharmaceuticals plc

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          December 3, 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Ap28

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          USD 0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          2,190,507

          2.24

          (2)   Cash-settled derivatives

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          Total

          2,190,507

          2.24

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant

          security

          USD 0.01 ordinary shares

          Purchase/sale

          purchase

          Number of

          securities

          4,305

          Price per unit

          (Note 5)

          $21.36

          Ap29

          (b)           Cash-settled derivative transactions

          • Class of

            relevant

            security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          • Class of

            relevant

            security

          • Product

            description e.g. call

            option

          • Writing, purchasing, selling, varying

            etc.

          • Number

            of

            securities

            to which

            option

            relates

            (Note 6)

          • Exercise

            price per

            unit

          • Type

            e.g.

            American,

            European

            etc.

          • Expiry

            date

          • Option

            money

            paid/

            received per unit

          (ii)           Exercise

          • Class of

            relevant

            security

          • Product

            description

            e.g. call

            option

          • Exercising/

            exercised

            against

          • Number of

            securities

          • Exercise

            price per

            unit

            (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          • Class of

            relevant

            security

          • Nature of dealing

            e.g. subscription,

            conversion, exercise

          • Details

          • Price per unit (if

            applicable)

            (Note 5)

          Ap30

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          • Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

            Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          • None

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          • None

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • NO

          Date of disclosure

          December 4, 2025

          Contact name

          Geode Compliance

          gcm_compliance@geodecapital.com

          Telephone number

          (800)-777-6757

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPFLFFEFTLSIIE

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - TIG Advisors, LLC Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.07%
          RNS Number : 3363K TIG Advisors, LLC 04 December 2025  

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          TIG Advisors, LLC

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          Avadel Pharmaceuticals plc

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          3 December 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          US$0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          3,728,144

          3.81%

          (2)   Cash-settled derivatives

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          Total

          3,728,144

          3.81%

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant

          security

           $0.01 ordinary shares

          Purchase/sale

          Purchase

          Number of

          securities

          100,000

          Price per unit

          (Note 5)

          USD 21.35

          (b)           Cash-settled derivative transactions

          • Class of

            relevant

            security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          • Class of

            relevant

            security

          • Product

            description e.g. call

            option

          • Writing, purchasing, selling, varying

            etc.

          • Number

            of

            securities

            to which

            option

            relates

            (Note 6)

          • Exercise

            price per

            unit

          • Type

            e.g.

            American,

            European

            etc.

          • Expiry

            date

          • Option

            money

            paid/

            received per unit

          (ii)           Exercise

          • Class of

            relevant

            security

          • Product

            description

            e.g. call

            option

          • Exercising/

            exercised

            against

          • Number of

            securities

          • Exercise

            price per

            unit

            (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          • Class of

            relevant

            security

          • Nature of dealing

            e.g. subscription,

            conversion, exercise

          • Details

          • Price per unit (if

            applicable)

            (Note 5)

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

          Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • NO

          Date of disclosure

          4 December 2025

          Contact name

          Cordelia Kim

          Telephone number

          +1 212-396-8669

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          NOTES ON FORM 8.3

          1.             See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

          2.             See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

          3.             See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

          4.             See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

          5.             If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

          6.             See Rule 2.5(d) of Part A of the Rules.

          7.             If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

          For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

          References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPFLFFEFILSIIE

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - BlackRock Group Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.07%
          Blackrock
          +0.17%
          RNS Number : 2885K BlackRock Group 04 December 2025  

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          BlackRock, Inc.

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          N/A

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          Avadel Pharmaceuticals plc

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          03 December 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          $0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          6,823,149

          6.95%

          2,934

          0.00%

          (2)   Cash-settled derivatives

          0

          0.00%

          4,268

          0.00%

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          0

          0.00%

          0

          0.00%

          Total

          6,823,149

          6.95%

          7,202

          0.00%

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant security

          $0.01 ordinary shares

          Purchase/sale

          Sale

          Number of securities

          1,230

          Price per unit

          (Note 5)

          USD 21.3600

          (b)           Cash-settled derivative transactions

          • Class of relevant security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          • Class of relevant security

          • Product

            description e.g. call

            option

          • Writing, purchasing, selling, varying

            etc.

          • Number of

            securities to which option relates (Note 6)

          • Exercise

            price per

            unit

          • Type

            e.g. American,

            European etc.

          • Expiry

            date

          • Option money

            paid/

            received per unit

          (ii)           Exercise

          • Class of relevant security

          • Product description

            e.g. call option

          • Exercising/

            exercised against

          • Number of securities

          • Exercise price per unit (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          Class of relevant

          security

          Nature of dealing

          e.g. subscription, conversion, exercise

          Details

          Price per unit (if applicable)

          (Note 5)

          $0.01 ordinary shares

          Stock on Loan

          76,800

          N/A

          $0.01 ordinary shares

          Return of Stock on Loan

          17,900

          N/A

          $0.01 ordinary shares

          Transfer in of Shares

          19,482

          N/A

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

          Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • NO

          Date of disclosure

          04 December 2025

          Contact name

          Jana Blumenstein

          Telephone number

          +44 20 7743 3650

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          NOTES ON FORM 8.3

          1.             See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

          2.             See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

          3.             See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

          4.             See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

          5.             If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

          6.             See Rule 2.5(d) of Part A of the Rules.

          7.             If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

          For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

          References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPPKQBBKBDDDBK

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - Citadel Group Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.07%
          RNS Number : 3133K Citadel Group 04 December 2025  

          Ap27

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          Citadel Group

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          N/A

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          AVADEL PHARMACEUTICALS PLC

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          N/A

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          3 December 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Ap28

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          Common Stock ISIN IE00BDGMC594

          $0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          997,740

          1.02

          277,101

          0.28

          (2)   Cash-settled derivatives

          0

          0.00

          0

          0.00

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          190,700

          0.19

          792,000

          0.81

          Total

          1,188,440

          1.21

          1,069,101

          1.09

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant

          security

          Purchase/sale

          Number of

          securities

          Price per unit

          (Note 5)

           Common

          Buy Transaction

          1,393

          21.3500 USD

           Common

          Buy Transaction

          8,147

          21.3502 USD

           Common

          Buy Transaction

          589

          21.3512 USD

           Common

          Buy Transaction

          500

          21.3530 USD

           Common

          Buy Transaction

          114

          21.3550 USD

           Common

          Buy Transaction

          155

          21.3550 USD

           Common

          Buy Transaction

          758

          21.3550 USD

           Common

          Buy Transaction

          32

          21.3556 USD

           Common

          Buy Transaction

          463

          21.3557 USD

           Common

          Buy Transaction

          12,913

          21.3570 USD

           Common

          Buy Transaction

          354

          21.3580 USD

           Common

          Buy Transaction

          1,420

          21.3584 USD

           Common

          Buy Transaction

          336

          21.3592 USD

           Common

          Buy Transaction

          834

          21.3597 USD

           Common

          Buy Transaction

          21,417

          21.3600 USD

           Common

          Buy Transaction

          1,000

          21.3601 USD

           Common

          Buy Transaction

          57

          21.3614 USD

           Common

          Buy Transaction

          219

          21.3632 USD

           Common

          Buy Transaction

          99

          21.3635 USD

           Common

          Buy Transaction

          677

          21.3639 USD

           Common

          Buy Transaction

          238

          21.3642 USD

           Common

          Buy Transaction

          2,953

          21.3643 USD

           Common

          Buy Transaction

          92

          21.3643 USD

           Common

          Buy Transaction

          177

          21.3647 USD

           Common

          Buy Transaction

          113

          21.3647 USD

           Common

          Buy Transaction

          1,711

          21.3649 USD

           Common

          Buy Transaction

          162

          21.3650 USD

           Common

          Buy Transaction

          103

          21.3670 USD

           Common

          Buy Transaction

          5,881

          21.3679 USD

           Common

          Buy Transaction

          104

          21.3680 USD

           Common

          Buy Transaction

          33,387

          21.3700 USD

           Common

          Buy Transaction

          9,500

          21.3711 USD

           Common

          Buy Transaction

          936

          21.3711 USD

           Common

          Buy Transaction

          490

          21.3711 USD

           Common

          Buy Transaction

          602

          21.3733 USD

           Common

          Buy Transaction

          9,757

          21.3736 USD

           Common

          Buy Transaction

          1,367

          21.3738 USD

           Common

          Buy Transaction

          648

          21.3746 USD

           Common

          Buy Transaction

          6,744

          21.3748 USD

           Common

          Buy Transaction

          291

          21.3748 USD

           Common

          Buy Transaction

          600

          21.3750 USD

           Common

          Buy Transaction

          1,053

          21.3761 USD

           Common

          Buy Transaction

          221

          21.3790 USD

           Common

          Buy Transaction

          436

          21.3799 USD

           Common

          Buy Transaction

          201

          21.3800 USD

           Common

          Buy Transaction

          1,564

          21.3800 USD

           Common

          Buy Transaction

          25

          21.3832 USD

           Common

          Buy Transaction

          300

          21.3833 USD

           Common

          Buy Transaction

          700

          21.3850 USD

           Common

          Buy Transaction

          419

          21.3852 USD

           Common

          Buy Transaction

          1,400

          21.3939 USD

           Common

          Buy Transaction

          700

          21.4000 USD

           Common

          Buy Transaction

          1

          21.4300 USD

           Common

          Sell Transaction

          3,025

          21.3500 USD

           Common

          Sell Transaction

          8,047

          21.3501 USD

           Common

          Sell Transaction

          36

          21.3511 USD

           Common

          Sell Transaction

          100

          21.3550 USD

           Common

          Sell Transaction

          1,025

          21.3550 USD

           Common

          Sell Transaction

          201

          21.3551 USD

           Common

          Sell Transaction

          1,107

          21.3555 USD

           Common

          Sell Transaction

          180

          21.3565 USD

           Common

          Sell Transaction

          641

          21.3586 USD

           Common

          Sell Transaction

          534

          21.3586 USD

           Common

          Sell Transaction

          557

          21.3589 USD

           Common

          Sell Transaction

          257

          21.3589 USD

           Common

          Sell Transaction

          218

          21.3592 USD

           Common

          Sell Transaction

          570

          21.3594 USD

           Common

          Sell Transaction

          110

          21.3596 USD

           Common

          Sell Transaction

          28,770

          21.3600 USD

           Common

          Sell Transaction

          634

          21.3606 USD

           Common

          Sell Transaction

          375

          21.3607 USD

           Common

          Sell Transaction

          22

          21.3614 USD

           Common

          Sell Transaction

          239

          21.3617 USD

           Common

          Sell Transaction

          9,400

          21.3623 USD

           Common

          Sell Transaction

          1,100

          21.3627 USD

           Common

          Sell Transaction

          650

          21.3631 USD

           Common

          Sell Transaction

          1,941

          21.3636 USD

           Common

          Sell Transaction

          109

          21.3638 USD

           Common

          Sell Transaction

          64

          21.3641 USD

           Common

          Sell Transaction

          678

          21.3652 USD

           Common

          Sell Transaction

          7

          21.3671 USD

           Common

          Sell Transaction

          30

          21.3673 USD

           Common

          Sell Transaction

          400

          21.3675 USD

           Common

          Sell Transaction

          2,517

          21.3680 USD

           Common

          Sell Transaction

          324

          21.3693 USD

           Common

          Sell Transaction

          4,678

          21.3697 USD

           Common

          Sell Transaction

          301

          21.3700 USD

           Common

          Sell Transaction

          31,235

          21.3700 USD

           Common

          Sell Transaction

          1,884

          21.3723 USD

           Common

          Sell Transaction

          400

          21.3725 USD

           Common

          Sell Transaction

          300

          21.3733 USD

           Common

          Sell Transaction

          500

          21.3750 USD

           Common

          Sell Transaction

          187

          21.3750 USD

           Common

          Sell Transaction

          100

          21.3756 USD

           Common

          Sell Transaction

          700

          21.3793 USD

           Common

          Sell Transaction

          279

          21.3798 USD

           Common

          Sell Transaction

          100

          21.3800 USD

           Common

          Sell Transaction

          359

          21.3834 USD

           Common

          Sell Transaction

          485

          21.3869 USD

           Common

          Sell Transaction

          140

          21.3873 USD

           Common

          Sell Transaction

          1,086

          21.3879 USD

           Common

          Sell Transaction

          222

          21.3880 USD

           Common

          Sell Transaction

          209

          21.3883 USD

           Common

          Sell Transaction

          106

          21.3883 USD

           Common

          Sell Transaction

          817

          21.3900 USD

           Common

          Sell Transaction

          471

          21.3923 USD

           Common

          Sell Transaction

          1,382

          21.4000 USD

           Common

          Sell Transaction

          400

          21.4050 USD

           Common

          Sell Transaction

          137

          21.4050 USD

           Common

          Sell Transaction

          174

          21.4085 USD

          Ap29

          (b)           Cash-settled derivative transactions

          • Class of

            relevant

            security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          Class of

          relevant

          security

          Product

          description e.g. call

          option

          Writing, purchasing, selling, varying

          etc.

          Number

          of

          securities

          to which

          option

          relates

          (Note 6)

          Exercise

          price per

          unit

          Type

          e.g.

          American,

          European

          etc.

          Expiry

          date

          Option

          money

          paid/

          received per unit

          Common

          Call Option

          Buy Transaction

          10,500

          20.0000 USD

          American

          2025-12-19

          1.3500 USD

          Common

          Call Option

          Buy Transaction

          6,000

          20.0000 USD

          American

          2025-12-19

          1.3600 USD

          Common

          Call Option

          Buy Transaction

          7,200

          20.0000 USD

          American

          2025-12-19

          1.4000 USD

          Common

          Call Option

          Buy Transaction

          100

          10.0000 USD

          American

          2027-01-15

          11.2300 USD

          (ii)           Exercise

          • Class of

            relevant

            security

          • Product

            description

            e.g. call

            option

          • Exercising/

            exercised

            against

          • Number of

            securities

          • Exercise

            price per

            unit

            (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          • Class of

            relevant

            security

          • Nature of dealing

            e.g. subscription,

            conversion, exercise

          • Details

          • Price per unit (if

            applicable)

            (Note 5)

          Ap30

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          • Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

            Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          • None

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          • None

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • YES

          Date of disclosure

          4 December 2025

          Contact name

          Paula Santos

          Telephone number

          020 7645 9700

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          Ap32

          SUPPLEMENTAL FORM 8

          IRISH TAKEOVER PANEL

          DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

          RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

          TAKEOVER RULES, 2022

          DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

          OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

          RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

          1.             KEY INFORMATION

          Full name of person making

          disclosure:

          Citadel Group

          Name of offeror/offeree in relation

          to whose relevant securities the

          disclosure relates:

          AVADEL PHARMACEUTICALS PLC

          2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

          Class of

          relevant

          security

          Product

          description

          e.g. call

          option

          Written or

          purchased

          Number of

          securities to

          which option

          or derivative

          relates

          Exercise

          price

          per unit

          Type

          e.g.

          American,

          European

          etc.

          Expiry

          date

          Common

          Put Option

          Purchased

          -900

          25.0 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -4,700

          15.0 USD

          American

          19/12/2025

          Common

          Call Option

          Purchased

          24,200

          22.5 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          0

          12.5 USD

          American

          15/01/2027

          Common

          Put Option

          Purchased

          -100

          20.0 USD

          American

          18/06/2026

          Common

          Call Option

          Purchased

          4,200

          17.5 USD

          American

          16/01/2026

          Common

          Call Option

          Purchased

          29,100

          20.0 USD

          American

          19/12/2025

          Common

          Put Option

          Purchased

          0

          10.0 USD

          American

          20/03/2026

          Common

          Call Option

          Purchased

          900

          7.5 USD

          American

          19/12/2025

          Common

          Call Option

          Purchased

          5,100

          22.5 USD

          American

          15/01/2027

          Common

          Call Option

          Purchased

          0

          5.0 USD

          American

          16/01/2026

          Common

          Put Option

          Purchased

          -3,100

          12.5 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -200

          17.5 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -60,700

          15.0 USD

          American

          16/01/2026

          Common

          Put Option

          Purchased

          -44,400

          10.0 USD

          American

          16/01/2026

          Common

          Put Option

          Purchased

          -2,900

          7.5 USD

          American

          19/12/2025

          Common

          Call Option

          Purchased

          0

          25.0 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -100

          7.5 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -3,800

          15.0 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -100

          15.0 USD

          American

          15/01/2027

          Common

          Call Option

          Purchased

          3,000

          25.0 USD

          American

          15/01/2027

          Common

          Put Option

          Purchased

          -1,000

          17.5 USD

          American

          18/06/2026

          Common

          Call Option

          Purchased

          5,600

          12.5 USD

          American

          15/01/2027

          Common

          Call Option

          Purchased

          5,100

          15.0 USD

          American

          15/01/2027

          Common

          Call Option

          Purchased

          2,200

          20.0 USD

          American

          18/06/2026

          Common

          Put Option

          Sold

          5,300

          20.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -46,200

          20.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -100

          35.0 USD

          American

          16/01/2026

          Common

          Put Option

          Sold

          24,900

          7.5 USD

          American

          16/01/2026

          Common

          Put Option

          Sold

          400

          20.0 USD

          American

          20/03/2026

          Common

          Put Option

          Sold

          5,500

          12.5 USD

          American

          16/01/2026

          Common

          Put Option

          Sold

          59,000

          5.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -4,900

          22.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -10,000

          17.5 USD

          American

          20/03/2026

          Common

          Call Option

          Sold

          -65,900

          12.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -100

          30.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -6,800

          25.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -38,000

          15.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -2,100

          12.5 USD

          American

          20/03/2026

          Common

          Put Option

          Sold

          1,600

          12.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -13,400

          10.0 USD

          American

          15/01/2027

          Common

          Call Option

          Sold

          -5,100

          10.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -30,000

          15.0 USD

          American

          20/03/2026

          Common

          Call Option

          Sold

          -1,700

          25.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -34,200

          5.0 USD

          American

          15/01/2027

          Common

          Call Option

          Sold

          -148,000

          15.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -6,200

          12.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -182,900

          10.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -9,600

          7.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -31,800

          17.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -100

          20.0 USD

          American

          15/01/2027

          Common

          Call Option

          Sold

          -5,400

          20.0 USD

          American

          20/03/2026

          Common

          Put Option

          Sold

          2,000

          17.5 USD

          American

          19/12/2025

          Common

          Put Option

          Sold

          8,200

          10.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -9,900

          22.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -2,600

          30.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -4,800

          17.5 USD

          American

          15/01/2027

          Common

          Put Option

          Sold

          4,400

          17.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -10,200

          7.5 USD

          American

          15/01/2027

          3.             AGREEMENTS TO PURCHASE OR SELL

          Full details should be given so that the nature of the interest or position can be fully understood:

          Ap33

          4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

          • Class of relevant security in relation to which subscription right exists:

          • Details, including nature of the rights concerned and relevant percentages:

          It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

          The currency of all prices and other monetary amounts should be stated.

          For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

          References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPTIBTTMTTMBBA

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2025 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Business

          White Label

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          FastBull Membership

          Not yet

          Purchase

          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com